WVXU: Certain cancer treatments & COVID-19 could lead to death

Recent research shows combinations of treatments given at certain times could mean worse outcomes

A University of Cincinnati study found that cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months prior to a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.

These findings were presented Saturday at the European Society for Medical Oncology Virtual Congress 2020.

Lead author Trisha Wise-Draper, MD, PhD, associate professor of medicine in the Division of Hematology and Oncology at UC, UC Health oncologist and member of the UC Cancer Center, and her team analyzed 3,600 patients from 122 institutions across the country for this study.

"Any way you slice it, this is not good news for patients who are fighting cancer," she says. "Targeted therapies, especially those causing immune cell depletion, used one to three months before (the diagnosis of COVID-19) are associated with very high mortality, up to 50%."

Read the full WVXU report.

Read the UC News release.

Photo of chemotherapy courtesy of the National Cancer Institute.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

How aerospace is turning to trustworthy AI

January 6, 2026

UC College of Engineering and Applied Science graduate Lynn Pickering talks to the Ohio Federal Research Network about her research into artificial intelligence and the future of AI in aerospace engineering.

3

UC's art collection on display at the Contemporary Arts Center

January 5, 2026

University of Cincinnati leaders joined WVXU's Cincinnati Edition to talk about the university’s 200-year-old art collection, a new exhibition at the Contemporary Arts Center and the release of a companion book exploring the collection’s role in education and public engagement.